Longevity Terms and Researches Guide

This comprehensive review article focuses on the development of anti-aging drugs and the signal pathways they target, highlighting the significant progress in the field of aging and longevity. The article begins by setting the context of aging as a complex, multifactorial process that leads to the manifestation of various chronic diseases. The research emphasizes that, despite the diversity in their mechanisms, anti-aging drugs commonly aim to mitigate the effects of aging by targeting specific cellular signaling pathways.

Among the pathways discussed, the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and silent information regulator factor 2-related enzyme 1 (SIRT1) pathways are notable for their pivotal roles in cellular aging processes. Each pathway has associated drugs like rapamycin, metformin, and others which are believed to confer benefits such as delayed aging, reduced incidence of age-related diseases, and improved systemic health.

The article further delves into the challenges and potential side effects associated with these drugs, emphasizing the necessity for ongoing research to balance efficacy and safety. The authors advocate for a nuanced understanding of how these pathways interconnect and influence aging, proposing that future therapies might involve combinations of drugs to target multiple pathways simultaneously, thus offering a more holistic approach to delaying the aging process and enhancing life quality in the elderly population.

The research article "Human Trials Exploring Anti-Aging Medicines" provides a comprehensive overview of the latest advancements in anti-aging treatments, focusing on both drugs and natural compounds. The authors analyze the efficacy and safety of several anti-aging substances that have undergone clinical trials. Notably, they discuss the promising results of substances like rapamycin, resveratrol, and NAD+ boosters, which have shown potential in extending healthspan and reducing age-related diseases. For example, metformin, traditionally used for diabetes management, has shown promise in extending health span in animal models and is now being tested in humans for various aging-related outcomes.

The study highlights the mechanisms through which these compounds exert their effects, such as activation of specific genes related to longevity and improvement in cellular functions. Key findings include the extension of healthspan in human subjects, reduction in biomarkers associated with aging, and improved metabolic health. The authors also address the challenges in translating these results from controlled clinical settings to real-world applications. Importantly, the research emphasizes the need for further large-scale studies to confirm these findings and to determine optimal dosages and treatment regimens for broader human use.

Ketone ester supplementation has been increasingly recognized for its potential anti-aging effects. This study explores the implications of ketone esters, specifically β-hydroxybutyrate (β-HB), on aging and longevity. The research highlights that ketone esters promote a state of ketosis without the strict dietary restrictions typically associated with ketogenic diets, making it a more accessible intervention for aging populations.

The BIKE (Buck Institute Ketone Ester) pilot study is particularly noteworthy as it represents the first human clinical trial to assess the anti-aging effects of ketone ester supplementation in individuals over 65. This 12-week, double-blind, randomized, placebo-controlled trial aims to determine if the positive outcomes observed in mice—such as extended lifespan and improved health markers—translate to humans. Participants undergo various physical and mental tests, and their biological markers are monitored throughout the study.

The results from this pioneering study could significantly influence future dietary recommendations and therapeutic interventions aimed at mitigating the effects of aging, thereby enhancing the quality of life for the elderly population.

This comprehensive review explores the intricate mechanisms of aging and the potential interventions using stem cells and various anti-aging drugs. The study elucidates how aging has traditionally been seen as an unavoidable decline in bodily functions but points towards a future where this might be mitigated through medical advancements. The authors delve into the biological and medical definitions of aging, describing it as a decline in physical and psychological adaptability. Central to their discussion are the mechanisms through which aging occurs, such as telomere shortening, changes in immune function, and the accumulation of senescent cells.

The review highlights several pathways and factors implicated in aging, like the Nrf2/SKN-1 and NFκB pathways, and introduces the criteria for determining potential anti-aging drugs, which include their ability to extend lifespan in model organisms and delay age-related diseases. Prominent among these drugs are rapamycin, metformin, and various natural polyphenols like curcumin and resveratrol, known for their life-extending and disease-preventing properties. The role of stem cells in combating aging is emphasized, with a focus on their ability to regenerate and repair tissues, thus potentially extending health span and delaying the onset of age-related diseases. The article provides a well-rounded view of the current research landscape in aging, underscoring the complexity of aging processes and the promising therapeutic avenues that stem cells and pharmacological interventions might offer.

This study, conducted by Hosoda, Nakashima, Yano, and colleagues, explores the impact of Resveratrol, a SIRT1 activator, on aging-related changes in skeletal muscle and heart function in mice. Administering Resveratrol to mice for 32 weeks beginning at 28 weeks of age demonstrated significant preservation of motor function, as evidenced by sustained performance on rotarod tests. The treatment effectively countered muscle atrophy in older mice, typically seen as a reduction in muscle fiber size and increased muscle fiber acetylation. In the heart, Resveratrol treatment prevented the enlargement of cardiomyocyte diameters typically associated with aging, indicating a reduction in aging-induced cardiomyocyte hypertrophy.

Additionally, the study found that Resveratrol enhances autophagic activity, which declines with age in both skeletal and cardiac muscles. By activating SIRT1, Resveratrol decreases acetylation levels within muscle fibers, promoting autophagy and contributing to the maintenance of muscle and heart health. These findings suggest that Resveratrol could be an effective intervention for mitigating aging-related muscle and heart deterioration, potentially improving quality of life in aging populations. The results hold promise for therapies aimed at enhancing SIRT1 activation to maintain muscle and heart function in the elderly.

The study titled "Rapamycin treatment increases survival, autophagy biomarkers, and expression of the anti-aging klotho protein in elderly mice," conducted by Kitti Szőke and colleagues in 2023, investigates the potential anti-aging effects of rapamycin on elderly mice. Rapamycin is known for its ability to inhibit the mTOR pathway, which is significantly involved in the aging process. In this research, elderly mice, specifically 24 months old, were administered rapamycin over a defined period to observe its effects on their lifespan and biological markers related to aging.

The results from the study were quite promising. Mice treated with rapamycin showed a noticeable increase in survival rates compared to those who received a control treatment. This suggests that rapamycin could have a direct beneficial impact on lifespan extension. Furthermore, the study delved into the cellular mechanisms behind these effects, finding a significant increase in the markers of autophagy—a process that helps clear damaged cells and proteins, thereby promoting cellular health and longevity. This indicates that rapamycin not only helps in extending life but also enhances the quality of cellular function in later life.

Additionally, the treatment positively affected the expression of klotho, a protein associated with longevity, particularly noted in the kidney cells of the treated mice. The klotho protein is often reduced in elderly individuals and is linked to various age-related diseases. The increase in klotho expression suggests that rapamycin may help mitigate some of the molecular declines associated with aging. This study provides valuable insights into how modifying molecular pathways like mTOR with drugs such as rapamycin can significantly impact health span and potentially delay the onset of age-related physiological decline.

This study delves into the pivotal role of Nicotinamide Adenine Dinucleotide (NAD+), a crucial molecule in maintaining cellular health, and its significant decline as organisms age. The decline in NAD+ levels is closely associated with various age-related diseases, including neurological disorders and metabolic dysfunctions. By investigating how NAD+ levels influence cellular functions, the research sheds light on potential interventions that could mitigate aging processes and improve overall healthspan.

One of the key findings highlighted in the study is the effectiveness of supplementing NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which have been shown to boost NAD+ levels in cells and, as a result, enhance cellular metabolism and vitality. The research discusses various animal model studies where increased NAD+ levels led to noticeable improvements in muscle function, brain health, and lifespan extension. For example, mice treated with NAD+ precursors exhibited enhanced physical activity and reduced signs of aging compared to control groups.

Moreover, the paper explores the therapeutic potential of targeting NAD+ pathways to treat age-related diseases. It mentions clinical trials that are examining the effects of NAD+ boosting strategies on human health, particularly focusing on their capacity to reverse aspects of aging and improve cognitive and metabolic functions. This emerging area of research holds promise not only for extending lifespan but also for enhancing the quality of life in later years, offering hope that aging could be a more vibrant and active phase of life rather than one dominated by decline.